Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001337474 | SCV001531077 | uncertain significance | Fanconi anemia | 2020-07-26 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 14 of the FANCA gene. It does not directly change the encoded amino acid sequence of the FANCA protein, but it affects a nucleotide within the consensus splice site of the intron. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with FANCA-related conditions. Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002486347 | SCV002791895 | uncertain significance | Fanconi anemia complementation group A | 2021-10-07 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001337474 | SCV002095045 | uncertain significance | Fanconi anemia | 2021-01-21 | no assertion criteria provided | clinical testing |